Time to Initiation of Hepatitis B Treatment is Reduced With the Use of the Xpert HBV Viral Load Kit
- PMID: 40352629
- PMCID: PMC12063097
- DOI: 10.1093/ofid/ofaf238
Time to Initiation of Hepatitis B Treatment is Reduced With the Use of the Xpert HBV Viral Load Kit
Abstract
Timely initiation of hepatitis B virus treatment is essential for improving prognosis and outcomes. In Ethiopia, the use of the Xpert hepatitis B virus viral load kit significantly shortened the turnaround time compared to standard laboratory methods. By reducing the time to a treatment decision to 1 day, the Xpert kit allowed for quicker treatment initiation at lower costs, potentially saving lives that might otherwise be lost due to treatment delays.
Keywords: antiviral therapy; hepatitis B; point-of-care; resource-limited settings; viral load.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. All authors declare no conflict of interest.
Figures


Similar articles
-
Validity of a point-of-care viral load test for hepatitis B in a low-income setting.J Virol Methods. 2021 Mar;289:114057. doi: 10.1016/j.jviromet.2020.114057. Epub 2020 Dec 29. J Virol Methods. 2021. PMID: 33359613
-
Real-world application of the Xpert® HBV viral load assay on serum and dried blood spots.J Med Virol. 2021 Jun;93(6):3707-3713. doi: 10.1002/jmv.26662. Epub 2020 Nov 22. J Med Virol. 2021. PMID: 33174623
-
Performance evaluation of Xpert HBV viral load (VL) assay: Point-of-care molecular test to strengthen and decentralize management of chronic hepatitis B (CHB) infection.J Virol Methods. 2021 Apr;290:114063. doi: 10.1016/j.jviromet.2021.114063. Epub 2021 Jan 13. J Virol Methods. 2021. PMID: 33453301
-
Hepatitis B viral load affects prognosis of hepatocellular carcinoma.World J Gastroenterol. 2014 Sep 14;20(34):12039-44. doi: 10.3748/wjg.v20.i34.12039. World J Gastroenterol. 2014. PMID: 25232241 Free PMC article. Review.
-
Antiviral therapies for hepatitis B virus-related hepatocellular carcinoma.World J Gastroenterol. 2015 Apr 7;21(13):3860-6. doi: 10.3748/wjg.v21.i13.3860. World J Gastroenterol. 2015. PMID: 25852270 Free PMC article. Review.
References
-
- World Health Organization . Global hepatitis report 2024: action for access in low-and middle-income countries. Geneva: WHO, 2024.
-
- World Health Organization . Global health sector strategy on viral hepatitis 2016–2021. Towards ending viral hepatitis. Geneva: WHO, 2016.
-
- Lampertico P, Agarwal K, Berg T, et al. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017; 67:370–98. - PubMed
LinkOut - more resources
Full Text Sources